https://www.selleckchem.com/pr....oducts/vanzacaftor.h
Functional imaging by standard whole-body (W F-flurodeoxyglucose (FDG) positron emission tomography (PET) is an integrated part of disease diagnostics. Recently, a clinical dynamic whole-body (D-W FDG PET/CT scanning protocols has been developed allowing for quantitative imaging of tissue metabolic rate of FDG (MR ). It was the purpose of this retrospective study to evaluate whether MR imaging is feasible in a clinical setting and whether it improves lesion detectability. One hundred nine patients representing a broad range of r
Like
Comment
Share
